NCCN Guidelines® Insights: Survivorship, Version 1.2022.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
10 2022
Historique:
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 19 10 2022
Statut: ppublish

Résumé

The NCCN Guidelines for Survivorship are intended to help healthcare professionals who work with survivors to ensure that the survivors' complex and varied needs are addressed. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for the consequences of adult-onset cancer and its treatment; recommendations to help promote physical activity, weight management, and immunizations in survivors; and a framework for care coordination. This article summarizes updates to the NCCN Guidelines pertaining to preventive health for cancer survivors, including recommendations about alcohol consumption and vaccinations.

Identifiants

pubmed: 36240847
doi: 10.6004/jnccn.2022.0052
pii: jnccn2010glins
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1080-1090

Auteurs

Tara Sanft (T)

Yale Cancer Center/Smilow Cancer Hospital.

Andrew Day (A)

UT Southwestern Simmons Comprehensive Cancer Center.

Lindsay Peterson (L)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

M Alma Rodriguez (MA)

The University of Texas MD Anderson Cancer Center.

Shannon Ansbaugh (S)

Patient advocate.

Saro Armenian (S)

City of Hope National Medical Center.

K Scott Baker (KS)

Fred Hutchinson Cancer Center.

Tarah Ballinger (T)

Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Gregory Broderick (G)

Mayo Clinic Cancer Center.

Wendy Demark-Wahnefried (W)

O'Neal Comprehensive Cancer Center at UAB.

Kristin Dickinson (K)

Fred & Pamela Buffett Cancer Center.

Nathan Paul Fairman (NP)

UC Davis Comprehensive Cancer Center.

Debra L Friedman (DL)

Vanderbilt-Ingram Cancer Center.

Mindy Goldman (M)

UCSF Helen Diller Family Comprehensive Cancer Center.

Norah Lynn Henry (NL)

University of Michigan Rogel Cancer Center.

Christine Hill-Kayser (C)

Abramson Cancer Center at the University of Pennsylvania.

Melissa Hudson (M)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Nazanin Khakpour (N)

Moffitt Cancer Center.

Divya Koura (D)

UC San Diego Moores Cancer Center.

Allison L McDonough (AL)

Massachusetts General Hospital Cancer Center.

Michelle Melisko (M)

UCSF Helen Diller Family Comprehensive Cancer Center.

Kathi Mooney (K)

Huntsman Cancer Institute at the University of Utah.

Halle C F Moore (HCF)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Natalie Moryl (N)

Memorial Sloan Kettering Cancer Center.

Heather Neuman (H)

University of Wisconsin Carbone Cancer Center.

Tracey O'Connor (T)

Roswell Park Comprehensive Cancer Center.

Linda Overholser (L)

University of Colorado Cancer Center.

Electra D Paskett (ED)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Chirayu Patel (C)

Massachusetts General Hospital Cancer Center.

William Pirl (W)

Dana-Farber/Brigham and Women's Cancer Center.

Andrea Porpiglia (A)

Fox Chase Cancer Center.

Kathryn J Ruddy (KJ)

Mayo Clinic Cancer Center.

Lidia Schapira (L)

Stanford Cancer Institute.

Lillie Shockney (L)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Sophia Smith (S)

Duke Cancer Institute.

Karen L Syrjala (KL)

Fred Hutchinson Cancer Center.

Amye Tevaarwerk (A)

University of Wisconsin Carbone Cancer Center.

Eric H Yang (EH)

UCLA Jonsson Comprehensive Cancer Center.

Phyllis Zee (P)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and.

Nicole R McMillian (NR)

National Comprehensive Cancer Network.

Deborah A Freedman-Cass (DA)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH